Abstract
Although nebulizer treatment has become widespread in otolaryngology, many issues, such as the indications, advantages, disadvantages and choice of drugs, need to be addressed. Reports of nebulizer treatment were considered, and a questionnaire survey was carried out to clarify the present situation of nebulizer treatment. A nebulizer apparatus was used in 100% of the hospital group, 98.2% of the clinic group, and 76.6% in the university group, so nebulizer use was lowest in the university group. It is generally considered that frequent and regular attendance at a hospital for nebulizer treatment is impractical. Jet type nebulizers are used at many hospitals and clinics. In sinusitis, the use of cefmenoxime (CMX) has increased compared to past reports. It is possible that, in the 15 years since CMX was approved for nebulizer use in 1996, its validity has been evaluated. In laryngitis, CMX accounts for 46.3% of the antibacterial drugs currently given via nebulizer. There are still many issues surrounding nebulizer treatment that need to be examined, including the kind of nebulizer being used, the drugs used, and concomitant drugs. It is important to evaluate the usefulness of nebulizer treatment correctly.
